Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
23.44
+1.25 (5.75%)
Nov 21, 2024, 12:03 PM EST - Market open
Rapport Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
58
Market Cap
857.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRAPP News
- 7 days ago - Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting - GlobeNewsWire
- 17 days ago - Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November - GlobeNewsWire
- 4 weeks ago - This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
- 2 months ago - Rapport semestriel Pilier 3 - 30 juin 2024 - GlobeNewsWire
- 2 months ago - Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences - GlobeNewsWire
- 3 months ago - Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen's 4th Annual Novel Mechanisms in Neuropsychiatry Summit - GlobeNewsWire
- 4 months ago - Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain - GlobeNewsWire
- 5 months ago - Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares and Concurrent Private Placement - GlobeNewsWire